1.
Shkliaiev S. Risk analysis for the definition of representative drug for the formation of the quality review at the pharmaceutical enterprise. Farm Zh [Internet]. 2019Mar.18 [cited 2024Mar.29];0(6):26-9. Available from: https://pharmj.org.ua/index.php/journal/article/view/563